… Moreover, endocrine therapy had no effect on survival outcomes (RFS: P = .10; OS: P = …
survival outcomes appeared in our experience with the addition of endocrine therapy for patients …

… overall survival of receptor positive patients in this study was due to their longer survival …
In contrast to this, DFI did not significantly differ in receptor positive versus negative patients. …

… The survival curve of the four groups based on the estrogen receptor (ER) status of the
primary (Prim) and metastatic (Met) lesion. Tumors are classified as positive (+) or negative ()) at …

… patients were identified with a significantly worse survival than that for an ER- and PR-positive
group of node-positive patients. … nisms in patient survival, and it could thus be desirable to …

… among Stage 1-11 patients in our study may be due to their generally high survival rate.
However, where prolonged survival is less expected, among patients at a more advanced stage (…

… The ER HSCORE was related to both response and overall survival; there was no
statistically significant correlation of PR with clinical response in this small number of patients. …

… In summary, after adjusting for factors known to significantly impact survival, higher ER/PR
expression status was associated with better DFS in patients with type I endometrial cancer, …

… In breast cancer, estrogen and progesterone receptors can … of patients with endometrial
carcinoma is related to estrogen and … cancer we analyzed the survival time of patients by stage. …

… In this study, patient survival is defined as the time elapsed between tumor excision and
death, whereas disease-free interval is the time between the excision of the primary breast …

… in survival in relation to estrogen receptor status reported a statistically significant improvement
in survival when a premenopausal patient … effect of estrogen receptor on survival. In the …